HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yuki Ichimura Selected Research

nuclear matrix protein 2

1/2024Possible correlation between serum interleukin-8 levels and the activity of myositis in anti-NXP2 antibody-positive dermatomyositis.
11/2023[Two cases of anti-nuclear matrix protein 2 antibody-positive dermatomyositis sine dermatitis with severe diffuse subcutaneous edema and dysphagia].
1/2022A 10-year-old girl with low-grade B cell lymphoma complicated by anti-nuclear matrix protein 2 autoantibody-positive juvenile dermatomyositis.
1/2022Anti-nuclear matrix protein 2 antibody-positive inflammatory myopathies represent extensive myositis without dermatomyositis-specific rash.
1/2021Clinically amyopathic dermatomyositis associated with anti-nuclear matrix protein 2 antibody.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yuki Ichimura Research Topics

Disease

13Dermatomyositis (Dermatopolymyositis)
01/2024 - 02/2012
12Myositis (Idiopathic Inflammatory Myopathies)
02/2024 - 02/2012
7Neoplasms (Cancer)
01/2024 - 02/2012
4Interstitial Lung Diseases (Interstitial Lung Disease)
01/2024 - 03/2021
4Dermatitis
11/2023 - 10/2020
4Erythema
10/2023 - 03/2021
3Inflammation (Inflammations)
04/2024 - 10/2020
3Systemic Scleroderma (Systemic Sclerosis)
11/2023 - 01/2019
3Psoriasis (Pustulosis Palmaris et Plantaris)
12/2022 - 10/2020
2Pneumonia (Pneumonitis)
02/2024 - 03/2023
2Muscular Diseases (Myopathy)
02/2024 - 03/2023
2Experimental Nervous System Autoimmune Disease
02/2024 - 03/2023
2Fibrosis (Cirrhosis)
11/2023 - 01/2019
2Amyopathic dermatomyositis
10/2022 - 01/2021
2Exanthema (Rash)
01/2022 - 03/2021
1Virus Diseases (Viral Diseases)
04/2024
1Acute Lung Injury
04/2024
1Edema (Dropsy)
11/2023
1Muscle Weakness
11/2023
1Deglutition Disorders (Dysphagia)
11/2023
1Hemangioma (Angioma)
11/2023
1Panniculitis
10/2023
1Calcinosis
01/2022
1Pruritus (Itching)
01/2022
1Atopic Dermatitis (Atopic Eczema)
01/2022
1Contact Dermatitis (Eczema, Contact)
01/2022
1Diarrhea
01/2022
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2022
1Pulmonary Hypertension
11/2021
1Atrophy
01/2021
1Necrosis
01/2021
1Polymyositis
05/2012
1Carcinogenesis
02/2012

Drug/Important Bio-Agent (IBA)

11AutoantibodiesIBA
02/2024 - 02/2012
5nuclear matrix protein 2IBA
01/2024 - 01/2021
4Ligases (Synthetase)IBA
02/2024 - 10/2021
4Proteins (Proteins, Gene)FDA Link
02/2024 - 02/2012
4AntibodiesIBA
02/2024 - 02/2012
4AutoantigensIBA
02/2024 - 02/2012
3AntigensIBA
02/2024 - 03/2023
3Immunoglobulin G (IgG)IBA
02/2024 - 01/2021
3EnzymesIBA
01/2024 - 10/2022
3Imiquimod (Aldara)FDA LinkGeneric
12/2022 - 10/2020
2Coenzyme A (CoA)IBA
02/2024 - 03/2023
2Oxidoreductases (Dehydrogenase)IBA
02/2024 - 03/2023
2Complement System Proteins (Complement)IBA
02/2024 - 03/2023
2Myosins (Myosin)IBA
02/2024 - 03/2023
2CytokinesIBA
01/2024 - 06/2022
2ChemokinesIBA
01/2024 - 06/2022
2apremilastIBA
11/2023 - 01/2022
2Bleomycin (Blenoxane)FDA LinkGeneric
11/2023 - 01/2019
2Phosphodiesterase 4 InhibitorsIBA
11/2023 - 01/2022
2UbiquitinIBA
10/2023 - 10/2022
2SteroidsIBA
10/2023 - 03/2021
2Adrenal Cortex Hormones (Corticosteroids)IBA
01/2022 - 03/2021
1Poly I-CIBA
04/2024
1Toll-Like Receptors (Toll-Like Receptor)IBA
04/2024
1Transfer RNA (tRNA)IBA
02/2024
1Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA
02/2024
1ImmunosorbentsIBA
01/2024
1Interleukin-8 (Interleukin 8)IBA
01/2024
1Creatine Kinase (Creatine Phosphokinase)IBA
11/2023
1Staphylococcal Protein A (Protein A)IBA
11/2023
1CarbohydratesIBA
11/2023
1Biomarkers (Surrogate Marker)IBA
11/2023
1Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
11/2023
1Mycophenolic Acid (Cellcept)FDA LinkGeneric
10/2023
1Intravenous Immunoglobulins (IVIG)FDA Link
10/2023
1Tacrolimus (Prograf)FDA LinkGeneric
10/2023
1IFIH1 Interferon-Induced HelicaseIBA
10/2023
1Histidine-tRNA LigaseIBA
03/2023
1Cadherins (E-Cadherin)IBA
01/2023
1halichondrin BIBA
01/2023
1eribulinFDA Link
01/2023
1Interleukin-18 (Interleukin 18)IBA
06/2022
1InterleukinsIBA
06/2022
1LigandsIBA
06/2022
1Immunosuppressive Agents (Immunosuppressants)IBA
01/2022
1DinitrofluorobenzeneIBA
01/2022
1SiliconesIBA
01/2022
1calcipotriene (calcipotriol)FDA LinkGeneric
01/2022
1InterferonsIBA
08/2021
1Interferon Type IIBA
01/2021
1transcriptional intermediary factor 1IBA
01/2021
1tofacitinibIBA
01/2021
1PerforinIBA
01/2021
1Interleukin-6 (Interleukin 6)IBA
10/2020
1Immune Checkpoint InhibitorsIBA
10/2020
1Phosphatidic Acids (Phosphatidic Acid)IBA
01/2019
1lysophosphatidic acidIBA
01/2019

Therapy/Procedure

1Intranasal Administration
04/2024
1Enteral Nutrition (Feeding, Tube)
11/2023
1General Anesthesia
11/2023
1Breast Implants (Breast Implant)
01/2022
1Therapeutics
08/2021
1Aftercare (After-Treatment)
03/2021